Delivery Order SPE2DB22D1202-SPE2DB24FVJY2

Award Date 8/6/24
Potential Completion Date 8/7/24
Potential Value $17K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The firm-fixed-price contract has a ceiling value of $1,404.96 and a completion date of August 7, 2024. AmerisourceBergen will deliver these medical supplies to support federal healthcare programs and facilities, including military treatment centers. This award is not associated with a set-aside...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has a ceiling value of $7,024.80 and an ultimate completion date of September 9, 2024. This award is a firm fixed-price delivery order with no set-aside designation. Amerisourcebergen holds several Indefinite Delivery Contracts (IDCs) with federal agencies, including a $999,999,999 IDC with...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The contract has a firm fixed price ceiling value of $58,558.76 and a period of performance through August 6, 2024. This award is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor in the United States. The $3,444.56 firm fixed price contract is for the supply of MENQUADFI VIAL 0.5ML, a medical product. The contract has an ultimate completion date of August 30, 2024. AmerisourceBergen holds several large Indefinite Delivery Contracts (IDCs) with DLA and other federal agencies, valued at up to $999,999,999 and $750,000 respectively, for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4565191480 - MENQUADFI VIAL 0.5ML. The fixed-price contract has a ceiling value of $3,161.16 and an ultimate completion date of July 19, 2024. Amerisourcebergen is a large, for-profit organization that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA), a defense agency, to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of MENQUADFI VIAL 0.5ML, a pharmaceutical product, with a ceiling value of $14,049.60 and a period of performance through May 10, 2024. The contract is a firm fixed-price, delivery order contract with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4558521104 MENQUADFI VIAL 0.5ML, a medical product, with a ceiling value of $1,418.56. The contract has a Firm Fixed Price pricing type and a completion date of September 21, 2022. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor. The contract, valued at $3,475.72, is for the supply of MENQUADFI VIAL 0.5ML, a medical product. It is a firm-fixed-price contract with an ultimate completion date of August 16, 2024. AmerisourceBergen holds significant Indefinite Delivery Contracts (IDCs) with the DLA Troop Support Medical, valued up to $999,999,999,...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical products. The $13,590.70 firm fixed price contract has a completion date of July 29, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, for delivering a comprehensive range of medical...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $6,952.19, is for the supply of MENQUADFI VIAL 0.5ML, a medical product. The contract is a firm-fixed price delivery order with a performance period running through February 25, 2025. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
  • SPE2DB22D1202
    Indefinite Delivery Contract
  • SPE2DB22D1202-SPE2DB24FVJY2
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of MENQUADFI VIAL 0.5ML medical supplies. The contract has a ceiling value of $16,859.52 and a period of performance through August 7, 2024. It is a firm fixed-price contract and does not have a set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies, collectively valued at up to $999,999,999, for delivering a wide range of pharmaceutical products and medical supplies to support military healthcare programs and other federal healthcare needs nationwide.

Generated 11/5/24, 9:19 AM